Glomerular involvement in myelodysplastic syndromes

R Bogdanović1, M Kuzmanović, J Marković-Lipkovski

  • 1Institute of Mother and Child Health of Serbia, 8 R. Dakica St., 11070 Belgrade, Yugoslavia. Maloun@eunet.yu

Insights

This study highlights myelodysplastic syndromes (MDS) as a cause of steroid-responsive nephrotic syndrome (NS) in children, a rare but important association. Early detection and treatment are crucial for managing these pediatric kidney and blood disorders.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Oncology

Background:

  • Glomerular diseases are documented in adults with myelodysplastic syndromes (MDS).
  • Similar reports in pediatric patients are scarce, necessitating further investigation into this association.
  • Myelodysplastic syndromes represent a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis and a high risk of transformation to acute myeloid leukemia.

Observation:

  • Two pediatric cases of myelodysplastic syndromes-associated steroid-responsive nephrotic syndrome (NS) are presented.
  • Patient 1 exhibited MDS with myelofibrosis, presenting with pancytopenia and nephrotic syndrome, responsive to high-dose steroids but with persistent hematologic issues.
  • Patient 2 had refractory anemia with monosomy 19, experiencing nephrotic syndrome and hematologic relapse responsive to corticosteroids, indicating a potential link between MDS and NS.

Findings:

  • Renal biopsy findings in both pediatric patients were consistent with idiopathic nephrotic syndrome.
  • A literature review identified 16 adult cases of glomerulopathy associated with MDS, manifesting as NS, renal insufficiency, and various glomerulonephritis types.
  • The study suggests that myelodysplastic syndromes can be associated with corticosteroid-responsive nephrotic syndrome in children, expanding the known spectrum of MDS complications.

Implications:

  • Pediatricians and hematologists should consider searching for glomerular disease in children diagnosed with myelodysplastic syndromes.
  • MDS should be recognized as a potential underlying cause of nephrotic syndrome in pediatric patients, particularly those with steroid-responsive disease.
  • This finding contributes to understanding the extraskeletal manifestations of myelodysplastic syndromes and informs diagnostic and therapeutic strategies in affected children.

Related Concept Videos